R&D and Innovation

The United States continues to fall further behind world leaders in funding for university research. To reverse course, it should increase support by $45 billion per year and provide stronger incentives for businesses to increase their investments.
R&D and Innovation
Check a box to narrow search for individual content items that cover numerous issues.
September 23, 2016
Chinese privately owned firms achieved an additional 0.16¥ in output for every yuan they invested in R&D, while state-owned firms created only 0.12¥ more output, writes John Wu in Innovation Files.
September 21, 2016
Stephen Ezell lectured on “Principles of Innovation in Government” at the University of Maryland on September 21, 2016.
September 20, 2016
Stephen Ezell lectured on Innovation and Evolutionary Economics as well as best practices in technology transfer and commercialization to the Technology Transfer Society’s USDA graduate education program.
September 10, 2016
Businesses in the European Union were investing 57 percent as much in R&D as their U.S. counterparts as of 2013, writes John Wu in Innovation Files.
September 6, 2016
From R&D and advanced manufacturing to the Internet and digital economy, Trump focuses more on reducing government barriers while Clinton focuses more on engaging government as an active partner alongside industry.
August 22, 2016
Stephen Ezell writes on the INSME blog about the types of innovation policies countries must get right for small- and medium-sized enterprises to flourish.
August 19, 2016
Taking more science classes in secondary school increases the student’s probability of enrolling in a university STEM program by 1.5 percentage points, writes John Wu in Innovation Files.
July 29, 2016
Over the past two decades, cheaper airline tickets had the knock-on effects of boosting research collaboration by 50 percent, writes John Wu in Innovation Files.
July 29, 2016
When the federal government committed $500 million to invest in a Manufacturing Innovation Institute, non-governmental entities pledged twice as much, writes John Wu in Innovation Files.
July 11, 2016
Spurring biopharmaceutical innovation to understand and cure brain diseases and disorders could improve health outcomes for more than 50 million Americans while increasing GDP by up to $1.5 trillion or more.